NYSE - Delayed Quote
USD
Cencora, Inc. (COR)
271.28
-0.55
(-0.20%)
At close: June 22 at 4:00:03 PM EDT
276.26
+4.98
(+1.84%)
Pre-Market: 6:13:16 AM EDT
Trade Cencora on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for COR
- Previous Close
271.83 - Open
272.66 - Bid --
- Ask --
- Day's Range
269.30 - 274.12 - 52 Week Range
244.82 - 377.54 - Volume
1,623,364 - Avg. Volume
1,760,595 - Market Cap (intraday)
52.781B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
20.79 - EPS (TTM)
13.05 - Earnings Date (est.) Aug 5, 2026
- Forward Dividend & Yield 2.40 (0.88%)
- Ex-Dividend Date May 15, 2026
- 1y Target Est
350.58
Recent News
View More
Performance Overview
Trailing total returns as of 6/22/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
COR
19.36%
S&P 500 (^GSPC)
9.16%
1-Year Return
COR
6.92%
S&P 500 (^GSPC)
25.22%
3-Year Return
COR
48.16%
S&P 500 (^GSPC)
70.54%
5-Year Return
COR
152.90%
S&P 500 (^GSPC)
75.98%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/22/2026
-
Market Cap
52.78B
-
Enterprise Value
62.99B
-
Trailing P/E
20.79
-
Forward P/E
13.59
-
PEG Ratio (5yr expected)
0.58
-
Price/Sales (ttm)
0.16
-
Price/Book (mrq)
15.53
-
Enterprise Value/Revenue
0.19
-
Enterprise Value/EBITDA
12.52
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.77%
-
Return on Assets (ttm)
3.49%
-
Return on Equity (ttm)
107.13%
-
Revenue (ttm)
328.68B
-
Net Income Avi to Common (ttm)
2.55B
-
Diluted EPS (ttm)
13.05
Balance Sheet and Cash Flow
-
Total Cash (mrq)
2.18B
-
Total Debt/Equity (mrq)
420.98%
-
Levered Free Cash Flow (ttm)
-318.25M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Daily – Vickers Top Buyers & Sellers for 05/29/2026
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
-
Cencora Earnings: Surprisingly Weak Sales Lead to Guidance Cut and Stock Selloff
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
RatingPrice Target -
Cencora Earnings: Surprisingly Weak Sales Lead to Guidance Cut and Stock Selloff
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
RatingPrice Target -
Reiterate BUY on price weakness
Headquartered in Conshohocken, Pennsylvania, Cencora, formerly AmerisourceBergen, is one of the nation's largest pharmaceutical distributors. The company distributes brand name and generic pharmaceuticals, over-the-counter (OTC) healthcare products, and home healthcare supplies and equipment to healthcare providers throughout the U.S. It also provides pharmaceuticals and pharmacy services to patients requiring specialty drugs such as immunology and oncology treatments. Cencora has international operations through its World Courier logistics business and assets acquired from Alliance Healthcare.
RatingPrice Target
